↓ Skip to main content

Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA’s Adverse Event Reporting System

Overview of attention for article published in Drug Safety, February 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#5 of 1,874)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
3 news outlets
blogs
1 blog
twitter
688 X users
facebook
12 Facebook pages
video
1 YouTube creator

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
48 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA’s Adverse Event Reporting System
Published in
Drug Safety, February 2018
DOI 10.1007/s40264-017-0620-4
Pubmed ID
Authors

Beatrice A. Golomb, Abril Verden, Alexis K. Messner, Hayley J. Koslik, Keith B. Hoffman

X Demographics

X Demographics

The data shown below were collected from the profiles of 688 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status Count As %
Other 10 21%
Researcher 8 17%
Student > Master 6 13%
Student > Ph. D. Student 3 6%
Student > Postgraduate 3 6%
Other 5 10%
Unknown 13 27%
Readers by discipline Count As %
Medicine and Dentistry 10 21%
Pharmacology, Toxicology and Pharmaceutical Science 6 13%
Neuroscience 5 10%
Biochemistry, Genetics and Molecular Biology 4 8%
Agricultural and Biological Sciences 3 6%
Other 5 10%
Unknown 15 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 483. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 April 2024.
All research outputs
#56,445
of 25,867,969 outputs
Outputs from Drug Safety
#5
of 1,874 outputs
Outputs of similar age
#1,392
of 454,842 outputs
Outputs of similar age from Drug Safety
#1
of 29 outputs
Altmetric has tracked 25,867,969 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,874 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 454,842 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.